When endometriosis occurs, endometrial tissue begins to increase outside of the uterus. Ovaries, fallopian tubes, and vaginal tissue were women's most frequently impacted organs. Beyond the pelvic region, the illness could spread. C-reactive protein sensitivity is greater in endometriosis patients compared to non-endometriosis individuals. Consequently, the test is frequently employed to diagnose patients with the disease and propel market expansion.
Data Bridge Market Research shows that the C–Reactive Protein Testing Market accounted for USD 1,750.27 million in 2021 and is expected to reach USD 1,995.10 million by 2029. The market is expected to grow with a CAGR of 1.65% from 2022 to 2029.
"Increasing Incidence of Inflammatory Disorders Will Aid Growth"
C-reactive protein tests identify inflammatory diseases like inflammatory bowel disease, endometriosis, cancer, rheumatoid arthritis, cardiovascular disease, and lupus. High CRP can be a symptom of serious heart disease when paired with other risk factors such as hypertension, high blood pressure, diabetes, and high cholesterol. The risk of heart attacks and strokes can be significantly reduced with early detection of cardiac illnesses. CRP is employed in developing innovative anti-inflammatory drugs in vitro and in vivo. These are the key elements that encourage market expansion.
What restraints the growth of C – Reactive Protein Testing Market?
"High Cost of C–Reactive Protein Testing Are Expected to Hamper the Market's Growth"
The high price of C-reactive protein testing and the low acceptance rate in developing and rising nations may hinder the market's expansion rate. C-reactive protein (CRP) quantitative blood test for $59.00, is offered by RequestATest.
Segmentation: C – Reactive Protein Testing Market
The C–reactive protein testing market is segmented on the basis of assay type, disease area, application, type of test, full test time, use, mobility and technology and end use.
- Based on product, the C–reactive protein testing market is segmented into enzyme linked immunosorbent assay, chemiluminiesence immunoassay, immunoturbidimetric assay, others.
- Based on type of test, the C–reactive protein testing market is segmented into molecular, serology.
- Based on type of full test time, the C–reactive protein testing market is segmented into 5 minutes, 5-15 minutes, 15-60 minutes, 1 hours- 5 hours, 5 hours-12 hours, 12 hours-24 hours, more than 1 days.
- Based on use, the C–reactive protein testing market is segmented into disposable, reusable.
- Based on mobility, the C–reactive protein testing market is segmented into portable, stationary.
- Based on technology, the C–reactive protein testing market is segmented into RT-PCR, Immunoglobulin G, Immunoglobulin M, ELISA Test, micro-neutralization assays.
- Based on disease are, the C–reactive protein testing market is segmented into cancer, lupus.
- Based on application, the C–reactive protein testing market is segmented into cardiovascular disease, inflammatory bowel disease, diabetes, rheumatoid arthritis and others.
- Based on end use, the C–reactive protein testing market is segmented into hospitals, clinics, public health labs, private or commercial labs, physician labs, research institutes, assisted living healthcare facilities, home, others.
Regional Insights: North America is expected to dominate the C– Reactive Protein Testing Market
The positive reimbursement practices expect North America to dominate the market. For instance, CRP measurement in the diagnosis of inflammatory diseases is covered by Blue Cross coverage for general inflammation testing.
In addition, the Asia-Pacific region is likely to register the highest growth rate during the forecast period of 2022 to 2029 due to increased government efforts to fund R&D initiatives and advance the healthcare industry. Additionally, technological advancements will fuel market development in the upcoming years. Direct CRP sensing was made possible by researchers who created a real-time flexible sensor incorporated into a medical catheter.
To know more about the study visit, https://www.databridgemarketresearch.com/zh/reports/global-c-reactive-protein-testing-market
Recent Developments in C – Reactive Protein Testing Market
- In 2021, the business invested $6 million in developing a new R&D Center in Chuncheon, South Korea. By March 2022, this facility is anticipated to be open for business.
The Prominent Key Players Operating in the C – Reactive Protein Testing Market Include:
- Thermo Fisher Scientific (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Danaher (U.S.)
- Quest Diagnostics Incorporated (U.S.)
- Siemens Healthineers AG (Germany)
- Abbott (U.S)
- Merck KGaAA (Germany)
- Zoetis (U.S.)
- Ortho Clinical Diagnostics (U.S.)
- Getein Biotech, Inc. (China)
- HORIBA, Ltd (Japan)
- Randox Laboratories Ltd. (U.K)
- BODITECH MED, INC. (South Korea)
- Aidian (Finland)
Above are the key players covered in the report, to know about more and exhaustive list of C–reactive protein testing market companies contact, https://www.databridgemarketresearch.com/zh/contact
Research Methodology: Global C – Reactive Protein Testing Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
